Northland Capmk Forecasts DocGo's Q2 Earnings (NASDAQ:DCGO)

Key Points

• Northland Capmk has issued Q2 2026 earnings estimates for DocGo Inc., predicting earnings of $0.01 per share, while the full-year estimate stands at $0.25 per share.
• The stock has faced negative revisions from analysts, with Canaccord Genuity cutting its price target from $5.00 to $1.45 and Needham decreasing theirs from $4.00 to $3.00.
• DocGo shares are trading down by 2.5%, with a current market price of $1.53 and a market capitalization of $156.03 million.

DocGo Inc. (NASDAQ:DCGO - Free Report) - Equities researchers at Northland Capmk issued their Q2 2026 earnings estimates for DocGo in a research note issued to investors on Monday, August 11th. Northland Capmk analyst M. Latimore anticipates that the company will earn $0.01 per share for the quarter. The consensus estimate for DocGo's current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo's Q3 2026 earnings at $0.03 EPS, Q4 2026 earnings at $0.03 EPS and FY2026 earnings at $0.04 EPS.

DCGO has been the topic of several other reports. Needham & Company LLC cut their price objective on shares of DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Canaccord Genuity Group restated a "hold" rating and issued a $1.45 price objective (down from $5.00) on shares of DocGo in a report on Monday, May 12th. Finally, BTIG Research lowered shares of DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $3.56.

DocGo Trading Down 0.6%

Shares of DCGO traded down $0.01 during mid-day trading on Tuesday, hitting $1.62. 956,426 shares of the company traded hands, compared to its average volume of 526,617. DocGo has a one year low of $1.23 and a one year high of $5.68. The business has a 50-day moving average of $1.52 and a 200 day moving average of $2.41. The stock has a market capitalization of $158.45 million, a price-to-earnings ratio of -8.53 and a beta of 0.96.

DocGo (NASDAQ:DCGO - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.06) by ($0.05). DocGo had a negative net margin of 4.20% and a negative return on equity of 3.26%. The company had revenue of $80.42 million for the quarter, compared to the consensus estimate of $77.58 million.

Institutional Investors Weigh In On DocGo

Several hedge funds have recently bought and sold shares of DCGO. Summit Securities Group LLC acquired a new stake in DocGo in the first quarter worth $34,000. CWM LLC raised its holdings in shares of DocGo by 2,613.3% during the second quarter. CWM LLC now owns 21,978 shares of the company's stock worth $35,000 after acquiring an additional 21,168 shares during the period. Cerity Partners LLC acquired a new stake in shares of DocGo during the second quarter worth $37,000. Summit Investment Advisors Inc. increased its stake in DocGo by 38.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company's stock valued at $45,000 after buying an additional 2,968 shares during the last quarter. Finally, Engineers Gate Manager LP acquired a new stake in DocGo in the 2nd quarter valued at $52,000. 56.44% of the stock is currently owned by institutional investors and hedge funds.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.